ロード中...
HMGB1 promotes differentiation syndrome by inducing hyperinflammation via MEK/ERK signaling in acute promyelocytic leukemia cells
Differentiation therapy based on all-trans-retinoic acid (ATRA) and arsenic trioxide (ATO) for the treatment of acute promyelocytic leukemia (APL) is complicated by the development of differentiation syndrome (DS), which can be fatal. We examined the role of HMGB1 (high-mobility group box 1) in DS u...
保存先:
| 出版年: | Oncotarget |
|---|---|
| 主要な著者: | , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Impact Journals LLC
2017
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5432337/ https://ncbi.nlm.nih.gov/pubmed/28404891 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.15432 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|